SCHEMBL23176646

SCHEMBL23176646

Cc1cc(C)c(-c2nc3cc(C)ccc3o2)c(C)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.65
RAB9A P51151 10/20 0.65
ALDH1A1 P00352 10/20 0.65
HPGD P15428 9/20 0.65
SMN1; SMN2 Q16637 9/20 0.65
NPC1 O15118 8/20 0.65
HSD17B10 Q99714 8/20 0.65
TP53 P04637 5/20 0.65
CASP3 P42574 4/20 0.61
SENP7 Q9BQF6 4/20 0.61
SENP6 Q9GZR1 4/20 0.61
SENP8 Q96LD8 3/20 0.61
POLB P06746 1/20 0.61
MAPT P10636 6/20 0.57
NFKB1 P19838 5/20 0.55
NFKB2 Q00653 5/20 0.55
RELA Q04206 5/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
GAA P10253 1/20 0.54
ALOX5 P09917 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12095312 0.85 RAB9A (0.69) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL4151604 0.83 ALDH1A1 (0.53) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL14668247 0.83 KDM4E (0.80) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL14699734 0.81 KDM4E (0.68) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL14947173 0.80 ALDH1A1 (0.96) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL3288386 0.79 ALDH1A1 (1.00) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL17562386 0.79 KDM4E (0.69) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL15047797 0.79 ALDH1A1 (0.93) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL17149170 0.78 SMN1; SMN2 (0.73) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL4544430 0.78 KDM4E (0.58) KDM4ERAB9AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210095196-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210095196-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES SSB, RO60, OSBP KDM4E 3361/4885RAB9A 428/4885ALDH1A1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.